Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

leflunomide

Trial Locations (26)

10021

Memorial Sloan-Kettering Cancer Center, New York

10032

New York Neurological Institute, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

12208

Cancer Center of Albany Medical Center, Albany

15224

Western Pennsylvania Cancer Institute, Pittsburgh

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

45219

Barrett Cancer Center, The University Hospital, Cincinnati

48202

Henry Ford Hospital, Detroit

52242

University of Iowa College of Medicine, Iowa City

53226

Medical College of Wisconsin, Milwaukee

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

77030

University of Texas - MD Anderson Cancer Center, Houston

80262

University of Colorado Cancer Center, Denver

85001-2071

St. Joseph's Hospital and Medical Center, Phoenix

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

46202-5265

Indiana University Cancer Center, Indianapolis

02215

Beth Israel Deaconess Medical Center, Boston

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

02903

Rhode Island Hospital, Providence

75235-9154

Simmons Cancer Center - Dallas, Dallas

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

British Columbia Cancer Agency, Vancouver

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

M5G 2M9

Princess Margaret Hospital, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Pfizer

INDUSTRY